| COVID-19 Clinical Research Studies | Lifetime | 116 | NO 1 | 99.32 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 228 | NO 1 | 99.28 |
| Long-Term Effects of COVID-19 | Lifetime | 130 | NO 1 | 98.59 |
| MicroRNA in disease regulation | Lifetime | 439 | NO 1 | 98.51 |
| Mesenchymal stem cell research | Lifetime | 280 | NO 1 | 98.50 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 567 | NO 1 | 98.38 |
| Ubiquitin and proteasome pathways | Lifetime | 406 | NO 2 | 98.17 |
| Immune cells in cancer | Lifetime | 401 | NO 1 | 97.76 |
| Nanoplatforms for cancer theranostics | Lifetime | 646 | NO 3 | 97.83 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 782 | NO 9 | 97.14 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 802 | NO 1 | 96.14 |
| Xenotransplantation and immune response | Lifetime | 141 | NO 1 | 95.74 |
| Nanoparticle-Based Drug Delivery | Lifetime | 994 | NO 1 | 96.63 |
| Renal cell carcinoma treatment | Lifetime | 964 | NO 2 | 96.43 |
| Extracellular vesicles in disease | Lifetime | 998 | NO 4 | 93.84 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 24 | NO 1 | 98.73 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 171 | NO 3 | 98.35 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 73 | NO 3 | 97.83 |
| Functional Brain Connectivity Studies | 2021-2025 | 167 | NO 2 | 98.11 |
| COVID-19 Clinical Research Studies | 2021-2025 | 513 | NO 1 | 97.68 |
| Immune cells in cancer | 2021-2025 | 171 | NO 1 | 96.15 |
| Immune Cell Function and Interaction | 2021-2025 | 416 | NO 2 | 94.96 |
| Long-Term Effects of COVID-19 | 2021-2025 | 575 | NO 3 | 95.05 |
| interferon and immune responses | 2021-2025 | 215 | NO 1 | 91.89 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 844 | NO 1 | 95.33 |
| Ubiquitin and proteasome pathways | 2021-2025 | 291 | NO 2 | 90.65 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 567 | NO 7 | 94.37 |
| Renal cell carcinoma treatment | 2021-2025 | 524 | NO 1 | 92.72 |
| Advanced MRI Techniques and Applications | 2021-2025 | 788 | NO 3 | 91.24 |
| Pancreatic function and diabetes | 2021-2025 | 556 | NO 3 | 91.53 |
| Spinal Fractures and Fixation Techniques | 2021-2025 | 661 | NO 1 | 91.22 |
| Medical Imaging and Analysis | 2021-2025 | 470 | NO 1 | 85.04 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 756 | NO 8 | 85.75 |
| Cancer-related Molecular Pathways | 2021-2025 | 584 | NO 1 | 78.56 |
| Mesenchymal stem cell research | 2021-2025 | 981 | NO 6 | 81.10 |
| Ultrasound and Hyperthermia Applications | 2021-2025 | 639 | NO 5 | 80.42 |
| Cervical and Thoracic Myelopathy | 2021-2025 | 583 | NO 5 | 78.88 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 804 | NO 1 | 76.03 |
| Fibroblast Growth Factor Research | 2021-2025 | 427 | NO 2 | 70.83 |
| Phagocytosis and Immune Regulation | 2021-2025 | 744 | NO 5 | 69.02 |
| Xenotransplantation and immune response | 2021-2025 | 372 | NO 1 | 48.13 |
